XBIT
XBiotech Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.20
−0.23%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-6.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Nov 12, 2025 | Rademaker Craig Evan · director | A-Award | 92,104 | $2.64 |
| Nov 12, 2025 | Soffer David Spencer · director | A-Award | 51,000 | $2.64 |
| Nov 12, 2025 | Kuendig Thomas Martin · director | A-Award | 79,115 | $2.64 |
| Nov 12, 2025 | Troy Tevi David · director | A-Award | 56,000 | $2.64 |
| Mar 19, 2025 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 1,026,228 | $3.52 |
| Jun 21, 2024 | MCKENZIE W THORPE · director, 10 percent owner: | A-Award | 37,500 | $5.12 |
| Jun 21, 2024 | Waldin Jan-Paul · director | A-Award | 37,500 | $5.12 |
| Jun 21, 2024 | MacAdam Donald H. · director | A-Award | 37,500 | $5.12 |
| Jun 21, 2024 | Libby Peter · director | A-Award | 37,500 | $5.12 |
| Jan 5, 2024 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 2,470,355 | $4.05 |
| Jun 26, 2023 | Waldin Jan-Paul · director | A-Award | 25,000 | $6.04 |
| Jun 26, 2023 | Libby Peter · director | A-Award | 25,000 | $6.04 |
| Jun 26, 2023 | MacAdam Donald H. · director | A-Award | 25,000 | $6.04 |
| Jun 26, 2023 | MCKENZIE W THORPE · director, 10 percent owner: | A-Award | 25,000 | $6.04 |
| Feb 17, 2023 | SHIVASWAMY SUSHMA · officer: Chief Scientific Officer | A-Award | 100,000 | $3.84 |
| Jun 27, 2022 | MacAdam Donald H. · director: | A-Award | 25,000 | $0.00 |
| Jun 27, 2022 | MCKENZIE W THORPE · director: | A-Award | 25,000 | $0.00 |
| Jun 27, 2022 | Waldin Jan-Paul · director: | A-Award | 25,000 | $0.00 |
| Jun 27, 2022 | Libby Peter · director: | A-Award | 25,000 | $0.00 |
| Feb 15, 2022 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 17,000 | $13 |
| Feb 15, 2022 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 33,000 | $13 |
| Jan 13, 2022 | MCKENZIE W THORPE · director, 10 percent owner: | M-Exempt | 250,000 | $10 |
| Jan 13, 2022 | MCKENZIE W THORPE · director, 10 percent owner: | F-InKind | 213,493 | $12 |
| Nov 23, 2021 | SHIVASWAMY SUSHMA · officer: Chief Scientific Officer | A-Award | 100,000 | $13 |
| Nov 23, 2021 | HAN QUEENA · officer: VP Finance & HR | A-Award | 35,000 | $13 |
| Oct 15, 2021 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 18,000 | $13 |
| Oct 15, 2021 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 10,875 | $13 |
| Oct 15, 2021 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 39,286 | $12 |
| Oct 15, 2021 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 21,125 | $13 |
| Oct 6, 2021 | SIMARD JOHN · director, 10 percent owner, officer: Chief Executive Officer | Sale | 23,681 | $13 |
Institutional positioning
13F filings over the trailing two quarters
New 8Increased 7Reduced 15Sold out 37
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 293,104 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 231,020 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 200,971 | May 15, 2026 |
| RBF CAPITAL, LLC | Unchanged | 198,501 | May 18, 2026 |
| MORGAN STANLEY | Reduced | 165,554 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 105,540 | May 15, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Increased | 98,447 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 91,576 | May 8, 2026 |
| NORTHERN TRUST CORP | Reduced | 76,087 | May 14, 2026 |
| STATE STREET CORP | Unchanged | 73,006 | May 15, 2026 |
| JANE STREET GROUP, LLC | Reduced | 60,100 | May 12, 2026 |
| EMPOWERED FUNDS, LLC | Unchanged | 59,547 | Jun 16, 2026 |
| SQUAREPOINT OPS LLC | Reduced | 41,214 | May 15, 2026 |
| BANK OF NEW YORK MELLON CORP | Reduced | 39,355 | May 5, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 36,689 | May 18, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Nov 12, 2025